Avery Therapeutics, Inc.
StreetZero Signal 74
About Avery Therapeutics, Inc.
Avery Therapeutics, Inc. develops immunomodulatory biologic therapies focused on tissue engineered therapeutics, regenerative medicine, and cardiology. The company aims to create novel therapeutics to improve human life through first-in-class approaches. It is headquartered in Tucson, Arizona, and was founded in 2016.
LATEST FUNDINGPrivate Placement
$8.5M
Announced 2026-09-21
TOTAL RAISED$20M
IN THE NEWS
- 🔗 Avery Therapeutics 2026 Company Profile: Valuation, Funding & Investors | PitchBook
- 🔗 Avery Therapeutics, Inc. - Immunomodulatory biologic therapies to improve human life.
- 🔗 Avery - 2026 Company Profile, Team, Funding & Competitors - Tracxn
- 🔗 Avery Therapeutics - Products, Competitors, Financials, Employees, Headquarters Locations
- 🔗 Avery Bio Corporation
EMPLOYEES2-10
FOUNDED2016
HQTucson, AZ, US
Industry
Biotechnology
Tags
BiotechnologyRegenerative MedicineTissue Engineering
Investors
Not disclosed in the source filing. Form D filings do not list investors — StreetZero surfaces them from news where available.
Key highlights
- Headquartered in Tucson, AZ with 2-10 employees.
- Specializes in immunomodulatory biologic therapies for cardiology and regenerative medicine.
- Has secured grant funding and venture rounds totaling approximately $20M.
- Holds patents related to three-dimensional tissue compositions.
Ask StreetZero about Avery Therapeutics, Inc.
Put our AI to work on this deal.
Similar companies
Other Biotechnology deals, ranked by Signal.
Source document & SEC filing
The source SEC filing and the cached document are available to members only. Sign in to view and download them.
Sign in to view the filing Create free account